Endeavour Mining Corp (EDV)
London Exchange · UK · prices in GBX · close of 21 Oct 2026
Key indicators
| Last close | GBX 4,121.00 |
|---|---|
| 52-week range | 2,818.42 – 5,461.90 |
| Return, 1 month / 3 months | −12.7% / +17.4% |
| Return, 1 year / 3 years | +39.0% / +168.5% |
| Trend | Below its 200-day average |
| RSI (14) | 43 |
| Volatility (1 year) | 48.0% |
| Worst drawdown (1 year) | -34.4% |
| Average daily value traded | 3,206.37M GBX |
| Dividend yield | 0.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Endeavour Mining is a gold producer focused on West Africa, where it operates several mines and processing plants across countries such as Burkina Faso, Côte d'Ivoire and Senegal. The company explores for, develops and extracts gold, and it also produces silver as a by-product at some operations. Its customers are mainly gold refiners and international bullion markets. The business is headquartered in London, with its operating and technical teams based in the region where its mines are located.
On this site Endeavour Mining Corp appears as a stock on the London Exchange (UK), code EDV, with prices in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Endeavour Mining Corp (EDV) trades on the London Exchange in UK. It last closed at GBX 4,121.00 on 21 October 2026.
Its price-based Market X-Ray is 56 out of 100 (a fair price profile), ranking 1,704 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 39.0% and over the last three months it rose 17.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 48 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -2.9% | ||
| From 52-week high | -19.8% | ||
| Momentum | 69 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 17.4% | ||
| 6-month return | -9.7% | ||
| 12-month return, skipping the last month | 59.2% | ||
| Stability (higher is calmer) | 35 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 48.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -34.4% | ||
| Liquidity | 99 · Strong | Trades actively. | |
| Average daily value traded | 3,206.37M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 28 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.0% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +3.3% |
|---|---|
| 1 month | −12.7% |
| 3 months | +17.4% |
| 6 months | −9.7% |
| 1 year | +39.0% |
| 3 years | +168.5% |
| 5 years | +162.4% |
Signals
| 50-day / 200-day average | 4,390.04 / 4,241.94 |
|---|---|
| Golden / death cross (60 days) | Golden, 17 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 160.03 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Sep 2026 | GBP 0.7127 |
| 12 Mar 2026 | GBP 0.6227 |
| 25 Sep 2025 | GBP 0.4651 |
| 13 Mar 2025 | GBP 0.4276 |
| 12 Sep 2024 | GBP 0.3076 |
| 22 Feb 2024 | GBP 0.3076 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.